Wall Street analysts expect Varex Imaging (NASDAQ:VREX) to report sales of $193.61 million for the current quarter, Zacks reports. Two analysts have provided estimates for Varex Imaging’s earnings, with the lowest sales estimate coming in at $193.20 million and the highest estimate coming in at $194.02 million. The company is expected to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Varex Imaging will report full-year sales of $193.61 million for the current year, with estimates ranging from $792.22 million to $792.30 million. For the next financial year, analysts expect that the business will post sales of $814.96 million per share, with estimates ranging from $814.70 million to $815.22 million. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Varex Imaging.

Varex Imaging (NASDAQ:VREX) last issued its earnings results on Thursday, November 9th. The company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The company had revenue of $216.00 million for the quarter, compared to analysts’ expectations of $213.73 million. The firm’s revenue was up 25.5% compared to the same quarter last year.

Several equities research analysts have weighed in on VREX shares. Zacks Investment Research downgraded shares of Varex Imaging from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. J P Morgan Chase & Co cut shares of Varex Imaging from a “neutral” rating to an “underweight” rating and set a $33.00 target price for the company. in a report on Wednesday, October 4th. Finally, Jefferies Group lifted their price objective on shares of Varex Imaging to $39.00 and gave the company a “buy” rating in a report on Friday, November 10th.

Shares of Varex Imaging (NASDAQ VREX) opened at $37.12 on Friday. Varex Imaging has a one year low of $25.00 and a one year high of $37.52. The company has a quick ratio of 1.72, a current ratio of 3.26 and a debt-to-equity ratio of 1.22.

In other news, insider Sunny Sanyal sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $36.50, for a total value of $1,825,000.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Security National Trust Co. purchased a new stake in shares of Varex Imaging in the 2nd quarter valued at approximately $108,000. Ameritas Investment Partners Inc. acquired a new position in shares of Varex Imaging in the 2nd quarter valued at $112,000. Howard Hughes Medical Institute acquired a new position in shares of Varex Imaging in the 2nd quarter valued at $134,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Varex Imaging in the 2nd quarter valued at $136,000. Finally, Hussman Strategic Advisors Inc. acquired a new stake in Varex Imaging during the 2nd quarter worth $147,000. 92.65% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Analysts Expect Varex Imaging (VREX) Will Announce Quarterly Sales of $193.61 Million” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/02/analysts-expect-varex-imaging-vrex-will-announce-quarterly-sales-of-193-61-million.html.

Varex Imaging Company Profile

Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.

Get a free copy of the Zacks research report on Varex Imaging (VREX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.